Cas No.: | 333994-00-6 |
Chemical Name: | 4-Piperidinecarboxamide, 1-acetyl-N-[3-[4-[[4-(aminocarbonyl)phenyl]methyl]-1-piperidinyl]propyl]-N-(3-chloro-4-methylphenyl)- |
Synonyms: | TAK 220;TAK220 |
SMILES: | C(N1CCC(C(N(CCCN2CCC(CC3C=CC(C(N)=O)=CC=3)CC2)C2C=CC(C)=C(Cl)C=2)=O)CC1)(=O)C |
Formula: | C31H41ClN4O3 |
M.Wt: | 553.1353 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A potent, specific, orally bioavailable CCR5 antagonist that blocks the binding of MIP-1α to CCR5 with IC50 of 1.4 nM; shows no affinity for CCR1, CCR2b, CCR3, CCR4, or CCR7; inhibits the replication of 6 CCR5-using (R5) HIV-1 clinical isolates in peripheral blood mononuclear cells (PBMCs) with mean EC90 of 13 nM; selectively inhibits R5 HIV-1 replication by interfering with coreceptor-mediated entry of the virus into host cells; exhibits a good pharmacokinetic profile in monkeys.HIV InfectionPhase 1 Clinical |